Oncotargets and Therapy

Papers
(The H4-Index of Oncotargets and Therapy is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression62
Perirenal Perivascular Epithelioid Cell Tumor (PEcoma) with Pulmonary Micro Invasive Adenocarcinoma: A Case Report and Literature Review51
Case Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation45
The Landscape of PARP Inhibitors in Solid Cancers43
Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor37
Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker37
Exploring Protein Expression Profiles in Lung Cancer Insufficient Microwave Ablation: Implications for Recurrence36
Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model34
MiR-17 and miR-93 Promote Tumor Progression by Targeting p21 in Patients with Chordoma32
MicroRNA-211 Promotes Non-Small-Cell Lung Cancer Proliferation and Invasion by Targeting MxA [Retraction]31
LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction]30
miR-132 Can Inhibit Glioma Cells Invasion and Migration by Target MMP16 in vitro [Retraction]30
Effects of Combined Inhibition of STAT3 and VEGFR2 Pathways on the Radiosensitivity of Non-Small-Cell Lung Cancer Cells [Retraction]30
microRNA-612 Suppresses the Malignant Development of Non-Small-Cell Lung Cancer by Directly Targeting Bromodomain-Containing Protein 4 [Retraction]29
Overexpressed Long Noncoding RNA TUG1 Affects the Cell Cycle, Proliferation, and Apoptosis of Pancreatic Cancer Partly Through Suppressing RND3 and MT2A [Retraction]28
Chidamide-Induced Accumulation of Reactive Oxygen Species Increases Lenalidomide Sensitivity Against Multiple Myeloma Cells27
Progress of Immune Checkpoint Inhibitors Therapy for pMMR/MSS Metastatic Colorectal Cancer27
An Innovative Site-Specific Anti-HER2 Antibody-Drug Conjugate with High Homogeneity and Improved Therapeutic Index26
Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer26
Anti-Tumor Effects of Gilteritinib on FLT3 Mutations: Insights into Resistance Mechanisms in Ba/F3 Cell Models26
β-Elemene Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin via Downregulation of Peroxiredoxin-125
Long Non-Coding RNA LINC01089 Enhances the Development of Gastric Cancer by Sponging miR-145-5p to Mediate SOX9 Expression [Retraction]25
Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives23
miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF123
0.15333795547485